{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/410267002"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Under the terms of the agreement, PharmaEngine will receive exclusive rights to develop and commercialize NBTXR3 in the Asian-Pacific region, including Australia, China, India, Japan, Korea, Taiwan and other countries, while Nanobiotix retains exclusive rights for the rest of the world." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "nanopaprika.eu" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/25185571"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/410267002" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/230490272"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/410267002" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/226177790"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/410267002" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/439471978"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/410267002"] } } }
